28508214|t|Efficient Reverse Genetic Systems for Rapid Genetic Manipulation of Emergent and Preemergent Infectious Coronaviruses
28508214|a|Emergent and preemergent coronaviruses (CoVs) pose a global threat that requires immediate intervention. Rapid intervention necessitates the capacity to generate, grow, and genetically manipulate infectious CoVs in order to rapidly evaluate pathogenic mechanisms, host and tissue permissibility, and candidate antiviral therapeutic efficacy. CoVs encode the largest viral RNA genomes at about 28-32,000 nucleotides in length, and thereby complicate efficient engineering of the genome. Deconstructing the genome into manageable fragments affords the plasticity necessary to rapidly introduce targeted genetic changes in parallel and assort mutated fragments while maximizing genome stability over time. In this protocol we describe a well-developed reverse genetic platform strategy for CoVs that is comprised of partitioning the viral genome into 5-7 independent DNA fragments (depending on the CoV genome), each subcloned into a plasmid for increased stability and ease of genetic manipulation and amplification. Coronavirus genomes are conveniently partitioned by introducing type IIS or IIG restriction enzyme recognition sites that confer directional cloning. Since each restriction site leaves a unique overhang between adjoining fragments, reconstruction of the full-length genome can be achieved through a standard DNA ligation comprised of equal molar ratios of each fragment. Using this method, recombinant CoVs can be rapidly generated and used to investigate host range, gene function, pathogenesis, and candidate therapeutics for emerging and preemergent CoVs both in vitro and in vivo.
28508214	0	9	Efficient	T080	C0442799
28508214	10	25	Reverse Genetic	T062	C1657306
28508214	26	33	Systems	T169	C0449913
28508214	44	64	Genetic Manipulation	T063	C0178659
28508214	68	76	Emergent	T078	C0750573
28508214	81	92	Preemergent	T078	C0750573
28508214	93	117	Infectious Coronaviruses	T047	C0206750
28508214	118	126	Emergent	T078	C0750573
28508214	131	142	preemergent	T078	C0750573
28508214	143	156	coronaviruses	T005	C0010076
28508214	158	162	CoVs	T005	C0010076
28508214	171	177	global	T080	C2348867
28508214	178	184	threat	T078	C0749385
28508214	209	221	intervention	T061	C0017296
28508214	223	241	Rapid intervention	T061	C0017296
28508214	259	267	capacity	T081	C1516240
28508214	271	279	generate	T052	C3146294
28508214	281	285	grow	T067	C2911660
28508214	291	313	genetically manipulate	T063	C0017387
28508214	314	329	infectious CoVs	T047	C0206750
28508214	350	358	evaluate	T052	C1516048
28508214	359	369	pathogenic	T033	C3816499
28508214	370	380	mechanisms	T169	C0441712
28508214	382	412	host and tissue permissibility	T039	C4277517
28508214	418	427	candidate	UnknownType	C0743153
28508214	428	458	antiviral therapeutic efficacy	T061	C0280274
28508214	460	464	CoVs	T005	C0010076
28508214	465	471	encode	T052	C2700640
28508214	484	493	viral RNA	T114	C0035736
28508214	494	501	genomes	T028	C0017428
28508214	521	532	nucleotides	T114	C0028630
28508214	536	542	length	T081	C1444754
28508214	556	566	complicate	T169	C0231242
28508214	567	576	efficient	T080	C0442799
28508214	577	602	engineering of the genome	T063	C0017387
28508214	604	629	Deconstructing the genome	T063	C0017387
28508214	646	655	fragments	T028	C1704681
28508214	668	678	plasticity	T070	C0678558
28508214	719	734	genetic changes	T049	C1705285
28508214	758	765	mutated	T045	C1513776
28508214	766	775	fragments	T028	C1704681
28508214	793	809	genome stability	T045	C1257825
28508214	815	819	time	T079	C0040223
28508214	829	837	protocol	T170	C2348563
28508214	867	891	reverse genetic platform	T062	C1657306
28508214	905	909	CoVs	T005	C0010076
28508214	931	943	partitioning	T169	C0332849
28508214	948	960	viral genome	T028	C0042720
28508214	982	995	DNA fragments	UnknownType	C0684192
28508214	1014	1017	CoV	T005	C0010076
28508214	1018	1024	genome	T028	C0017428
28508214	1032	1041	subcloned	T059,T063	C0598888
28508214	1049	1056	plasmid	T114,T123	C0032136
28508214	1061	1070	increased	T081	C0205217
28508214	1071	1080	stability	T045	C1257825
28508214	1093	1113	genetic manipulation	T063	C0178659
28508214	1118	1131	amplification	T045	C0017256
28508214	1133	1144	Coronavirus	T005	C0010076
28508214	1145	1152	genomes	T028	C0017428
28508214	1170	1181	partitioned	T169	C0332849
28508214	1197	1205	type IIS	T116,T126	C0012906
28508214	1209	1231	IIG restriction enzyme	T116,T126	C0012906
28508214	1232	1249	recognition sites	T086	C1882940
28508214	1262	1281	directional cloning	T059,T063	C0598888
28508214	1294	1310	restriction site	T086	C1882940
28508214	1354	1363	fragments	T028	C1704681
28508214	1365	1405	reconstruction of the full-length genome	T063	C0017387
28508214	1441	1453	DNA ligation	T045	C1155649
28508214	1494	1502	fragment	T031	C0486805
28508214	1515	1521	method	T170	C0025663
28508214	1523	1539	recombinant CoVs	T005	C0597363
28508214	1547	1564	rapidly generated	T052	C3146294
28508214	1589	1599	host range	T070	C2936413
28508214	1601	1614	gene function	T045	C0314627
28508214	1616	1628	pathogenesis	T046	C0699748
28508214	1634	1643	candidate	UnknownType	C0743153
28508214	1644	1656	therapeutics	T061	C0087111
28508214	1661	1669	emerging	T078	C0750573
28508214	1674	1685	preemergent	T078	C0750573
28508214	1686	1690	CoVs	T005	C0010076
28508214	1696	1704	in vitro	T080	C1533691
28508214	1709	1716	in vivo	T082	C1515655